BCG revaccination involves administering an additional dose of the Bacillus Calmette-Guérin vaccine, primarily to enhance immunity against tuberculosis. While some studies suggest potential benefits, the practice remains controversial due to inconsistent evidence on its efficacy and safety, leading to varying recommendations across different countries.